Bausch Health Companies Inc. 4

Aimee J. Lenar, President, US Pharma of Bausch Health Companies Inc. (BHC), sold 36,827 common shares at about $7.03 each under a Rule 10b5-1 plan.

On August 19, 2026, Aimee J. Lenar, President, US Pharma of Bausch Health Companies Inc., sold 36,827 common shares in an open-market transaction at an average price of approximately $7.03 per share, for total proceeds of about $258,900, under a pre-established Rule 10b5-1 trading plan adopted on May 21, 2026. Following this sale, her direct ownership stands at 334,853 common shares, which, using the current market price of around $6.94 per share, represents an equity stake valued at approximately $2.32 million.

Filing Facts

CIK

885590

Ticker

BHC

Form

4

Source Type

fda

Accession

0000885590-26-000109

Alert Tier

6